Renee de Leeuw

Featured in:

Articles

Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer | Journal of Clinical Oncology

Aug 15, 2023 | brnw.ch | Susan F. Slovin |Karen Knudsen |Susan Halabi |Renee de Leeuw

CONTEXTKey ObjectiveIs the frontline combination of abiraterone acetate/prednisone and cabazitaxel (AAP + C) in comparison with AAP alone beneficial to patients with metastatic castration-resistant prostate cancer (mCRPC) who are naïve to chemotherapy or androgen receptor signaling inhibitors?

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.